Stopping GLP-1 drugs can quickly erase cardiovascular benefits – WashU Medicine
WashU Medicine research shows cardiovascular benefits from GLP-1 drugs quickly vanish after stopping treatment, raising concerns about adherence.
WashU Medicine research shows cardiovascular benefits from GLP-1 drugs quickly vanish after stopping treatment, raising concerns about adherence.
Indian pharma companies are releasing low-cost alternatives to Novo Nordisk’s semaglutide drugs at fraction of branded prices.
Experts emphasize diet and exercise remain crucial despite surging demand for GLP-1 weight loss medications like Ozempic and Wegovy.
Experts caution that while NAD+ supplements boost cellular markers, evidence for actual anti-aging benefits in humans remains limited.
FDA label updates for menopause hormone therapy renew scientific debate about treatment risks and benefits for millions of women.
Haute MD Network outlines three strategic entry points for beginning peptide therapy focused on longevity and wellness optimization.
Generic semaglutide now sells for $14 monthly in India, a fraction of U.S. prices for Ozempic and Wegovy.
Clinical trial shows Botox Cosmetic may effectively treat visible neck bands caused by platysma muscle prominence.
New review examines how menopause affects mood and cognition, and whether hormone therapy can help preserve mental function.
Low-dose estrogen therapy for menopause can start as low as 0.014 mg, offering symptom relief with potentially reduced risks.